As patient input in drug development increases and new data sources are tapped, regulators need to organize and ensure the quality of data to inform decision-making.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1126/scitranslmed.aad5233 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!